Any hurdles, page-2

The biggest risk is what I call being "Contract rich, cashflow poor". We are a little exposed until consistent sales revenue overtakes lumpy one-off revenue.

My out of left field concerns are:

1. the factory catching fire

2. disgruntled ex-employees shooting up the place and

3. the FDA shutting down Hikma generics operations (I believe Hikma took market share in the USA when a competitor (Indian mob owned by Daichi Sankyo) got shut down by the FDA for poor quality standards).

I'm being serious here. I have a very active imagination. I suppose floods, pestilence and zombies also.